4/24
03:27 pm
ivvd
Invivyd (IVVD) Announces Favorable Phase 3 Analysis for VYD2311 COVID-19 Treatment [Yahoo! Finance]
Low
Report
Invivyd (IVVD) Announces Favorable Phase 3 Analysis for VYD2311 COVID-19 Treatment [Yahoo! Finance]
4/20
07:01 am
ivvd
Invivyd Announces Chairman Marc Elia to Speak at POLITICO Health Care Summit
Low
Report
Invivyd Announces Chairman Marc Elia to Speak at POLITICO Health Care Summit
4/9
05:16 pm
ivvd
Invivyd Updates VYD2311 REVOLUTION Trials, Modestly Upsizes Study, Unveils Measles mAb VMS-063 [Yahoo! Finance]
Low
Report
Invivyd Updates VYD2311 REVOLUTION Trials, Modestly Upsizes Study, Unveils Measles mAb VMS-063 [Yahoo! Finance]
4/9
07:01 am
ivvd
Invivyd Announces REVOLUTION Program Progress and Advancement of Novel, Potential First- and Best-in-Class Measles Monoclonal Antibody Candidate VMS063 for Treatment and Prevention of Measles
High
Report
Invivyd Announces REVOLUTION Program Progress and Advancement of Novel, Potential First- and Best-in-Class Measles Monoclonal Antibody Candidate VMS063 for Treatment and Prevention of Measles
4/7
07:01 am
ivvd
Invivyd Launches “Antibodies for Any Body” in Partnership with World Champion Skier Lindsey Vonn to Inspire Actions that Help Support Immune Health
Low
Report
Invivyd Launches “Antibodies for Any Body” in Partnership with World Champion Skier Lindsey Vonn to Inspire Actions that Help Support Immune Health
4/6
07:01 am
ivvd
Invivyd Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Low
Report
Invivyd Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
3/30
04:05 pm
ivvd
Invivyd Announces Presentation at the World Vaccine Congress Washington
Medium
Report
Invivyd Announces Presentation at the World Vaccine Congress Washington
3/20
11:27 am
ivvd
Invivyd: A Logical Bull Thesis With A Major Catalyst Approaching [Seeking Alpha]
Low
Report
Invivyd: A Logical Bull Thesis With A Major Catalyst Approaching [Seeking Alpha]
3/5
09:32 pm
ivvd
Invivyd Q4 Earnings Call Highlights [Yahoo! Finance]
Medium
Report
Invivyd Q4 Earnings Call Highlights [Yahoo! Finance]
3/5
12:51 pm
ivvd
Invivyd, Inc. Q4 2025 Earnings Call Summary [Yahoo! Finance]
Medium
Report
Invivyd, Inc. Q4 2025 Earnings Call Summary [Yahoo! Finance]
3/5
11:30 am
ivvd
Invivyd, Inc. (IVVD) Q4 2025 Earnings Call Transcript [Seeking Alpha]
Medium
Report
Invivyd, Inc. (IVVD) Q4 2025 Earnings Call Transcript [Seeking Alpha]
3/5
07:41 am
ivvd
Invivyd Reports Fourth Quarter and Full-Year 2025 Financial Results and Provides Recent Business Highlights and DECLARATION Clinical Trial Updates [Yahoo! Finance]
Low
Report
Invivyd Reports Fourth Quarter and Full-Year 2025 Financial Results and Provides Recent Business Highlights and DECLARATION Clinical Trial Updates [Yahoo! Finance]
3/5
07:41 am
ivvd
Invivyd Appoints Distinguished Physician and Scientist, Michael Mina, M.D., Ph.D. as Chief Medical Officer [Yahoo! Finance]
Low
Report
Invivyd Appoints Distinguished Physician and Scientist, Michael Mina, M.D., Ph.D. as Chief Medical Officer [Yahoo! Finance]
3/5
07:03 am
ivvd
Invivyd Reports Fourth Quarter and Full-Year 2025 Financial Results and Provides Recent Business Highlights and DECLARATION Clinical Trial Updates
Low
Report
Invivyd Reports Fourth Quarter and Full-Year 2025 Financial Results and Provides Recent Business Highlights and DECLARATION Clinical Trial Updates
3/5
07:01 am
ivvd
Invivyd Appoints Distinguished Physician and Scientist, Michael Mina, M.D., Ph.D. as Chief Medical Officer
Low
Report
Invivyd Appoints Distinguished Physician and Scientist, Michael Mina, M.D., Ph.D. as Chief Medical Officer
3/2
04:40 pm
ivvd
Invivyd to Host Fourth Quarter and Full-Year 2025 Financial Results and Corporate Update Conference Call on March 5, 2026 [Yahoo! Finance]
Medium
Report
Invivyd to Host Fourth Quarter and Full-Year 2025 Financial Results and Corporate Update Conference Call on March 5, 2026 [Yahoo! Finance]
3/2
04:14 pm
ivvd
Invivyd Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]
Medium
Report
Invivyd Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]
3/2
04:10 pm
ivvd
Invivyd to Host Fourth Quarter and Full-Year 2025 Financial Results and Corporate Update Conference Call on March 5, 2026
Medium
Report
Invivyd to Host Fourth Quarter and Full-Year 2025 Financial Results and Corporate Update Conference Call on March 5, 2026
3/2
04:01 pm
ivvd
Invivyd Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Medium
Report
Invivyd Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2/26
08:03 am
ivvd
Invivyd (IVVD) had its "buy" rating reaffirmed by BTIG Research. They now have a $10.00 price target on the stock.
Low
Report
Invivyd (IVVD) had its "buy" rating reaffirmed by BTIG Research. They now have a $10.00 price target on the stock.
2/24
07:01 am
ivvd
New Publication Demonstrates Variant-Agnostic Correlate of Protection from COVID-19 for Invivyd Monoclonal Antibody, Useful for Understanding of and Confidence in COVID-19 Antibodies
Low
Report
New Publication Demonstrates Variant-Agnostic Correlate of Protection from COVID-19 for Invivyd Monoclonal Antibody, Useful for Understanding of and Confidence in COVID-19 Antibodies
2/3
07:52 am
ivvd
Invivyd Aligns with the U.S. FDA on LIBERTY, a Phase 3 Trial to Evaluate the Safety of VYD2311 Antibody Versus mRNA COVID Vaccine, and to Characterize the Safety and Immunology of Antibody and Vaccine Co-Administration [Yahoo! Finance]
Low
Report
Invivyd Aligns with the U.S. FDA on LIBERTY, a Phase 3 Trial to Evaluate the Safety of VYD2311 Antibody Versus mRNA COVID Vaccine, and to Characterize the Safety and Immunology of Antibody and Vaccine Co-Administration [Yahoo! Finance]
2/3
07:01 am
ivvd
Invivyd Aligns with the U.S. FDA on LIBERTY, a Phase 3 Trial to Evaluate the Safety of VYD2311 Antibody Versus mRNA COVID Vaccine, and to Characterize the Safety and Immunology of Antibody and Vaccine Co-Administration
Medium
Report
Invivyd Aligns with the U.S. FDA on LIBERTY, a Phase 3 Trial to Evaluate the Safety of VYD2311 Antibody Versus mRNA COVID Vaccine, and to Characterize the Safety and Immunology of Antibody and Vaccine Co-Administration
1/24
03:28 pm
ivvd
How Recent Price Target Resets Are Rewriting The Story For Invivyd (IVVD) [Yahoo! Finance]
Medium
Report
How Recent Price Target Resets Are Rewriting The Story For Invivyd (IVVD) [Yahoo! Finance]